Last update 21 Nov 2024

Valsartan/Amlodipine/CHLORTHALIDONE

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
AT1R x NCC x VDCCs
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers)
Therapeutic Areas
Cardiovascular Diseases
Active Indication
Essential Hypertension
Inactive Indication-
Originator Organization
Aju Pharm Co. Ltd.
Active Organization
Aju Pharm Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H29N5O3
InChIKeyACWBQPMHZXGDFX-QFIPXVFZSA-N
CAS Registry137862-53-4
View All Structures (3)

Related

2
Clinical Trials associated with Valsartan/Amlodipine/CHLORTHALIDONE
NCT06416865 / RecruitingPhase 3
A Randomized, Double-blind, Multi-center, Phase III Trial to Evaluate the Efficacy and Safety of AJU-C52 in Compared With C52R1M for Essential Hypertension Patients in Inappropriately Controlled on C52R1L Treatment
NCT05077475 / Unknown statusPhase 1
An Open Label, Randomized, Single Dose, 2-sequence, 2-period, Cross-over Phase 1 Study to Evaluate the Safety and Pharmacokinetics of AJU-C52L Compared to Coadministration of C52R1H With C52R2 in Healthy Adult Volunteers
100 Clinical Results associated with Valsartan/Amlodipine/CHLORTHALIDONE
Login to view more data
100 Translational Medicine associated with Valsartan/Amlodipine/CHLORTHALIDONE
Login to view more data
100 Patents (Medical) associated with Valsartan/Amlodipine/CHLORTHALIDONE
Login to view more data
100 Deals associated with Valsartan/Amlodipine/CHLORTHALIDONE
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Essential HypertensionPhase 3
KR
Aju Pharm Co. Ltd.
27 Jun 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free